Erythropoietin Protects Adult Retinal Ganglion Cells against NMDA-, Trophic Factor Withdrawal-, and TNF-α-Induced Damage

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chang, Zhi Yang ^a   Yeh, Ming Kung ^a   Chiang, Chiao Hsi ^a   Chen, Yi Hao ^b   Lu, Da Wen ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; IMMUNOCYTOCHEMISTRY; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; RAT; RETINA GANGLION CELL;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL CULTURE TECHNIQUES; CILIARY NEUROTROPHIC FACTOR; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; FORSKOLIN; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; N-METHYLASPARTATE; RATS; RETINAL GANGLION CELLS; TOXICITY TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873805700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055291     Document Type: Article

References (53)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
2. Chidlow G, Wood JP, Casson RJ, (2007) Pharmacological neuroprotection for glaucoma. Drugs 67: 725-759.
3. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, et al. (2006) Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 26: 12633-12641.
4. Zhou X, Li F, Kong L, Tomita H, Li C, et al. (2005) Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem 280: 31240-31248.
5. Fuchs C, Forster V, Balse E, Sahel JA, Picaud S, et al. (2005) Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells. Invest Ophthalmol Vis Sci 46: 2983-2991.
6. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, et al. (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43: 1077-1087.
7. Casson RJ, (2006) Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin Experiment Ophthalmol 34: 54-63.
8. Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, et al. (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 41: 3460-3466.
9. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ, (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41: 764-774.
10. Osborne NN, (2009) Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol 87: 450-454.
11. Siren AL, Ehrenreich H, (2001) Erythropoietin-a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 251: 179-184.
12. Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, et al. (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45: 1514-1522.
13. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, et al. (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 48: 1212-1218.
14. Tsai JC, Wu L, Worgul B, Forbes M, Cao J, (2005) Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 30: 1025-1031.
15. Jehle T, Meschede W, Dersch R, Feltgen N, Bach M, et al. (2009) [Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression.]. Ophthalmologe.
16. Brooks DE, Komaromy AM, Kallberg ME, (1999) Comparative retinal ganglion cell and optic nerve morphology. Vet Ophthalmol 2: 3-11.
17. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA, (1987) Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 28: 913-920.
18. Glovinsky Y, Quigley HA, Dunkelberger GR, (1991) Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 32: 484-491.
19. Mey J, Thanos S, (1993) Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602: 304-317.
20. Watanabe M, Sawai H, Fukuda Y, (1995) Number and dendritic morphology of retinal ganglion cells that survived after axotomy in adult cats. J Neurobiol 27: 189-203.
21. Pang IH, Zeng H, Fleenor DL, Clark AF, (2007) Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci 8: 11.
22. Chang ZY, Lu DW, Yeh MK, Chiang CH, (2012) A novel high-content flow cytometric method for assessing the viability and damage of rat retinal ganglion cells. PLoS One 7: e33983.
23. Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA, (2008) Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Vis Sci 49: 4515-4522.
24. Luo X, Heidinger V, Picaud S, Lambrou G, Dreyfus H, et al. (2001) Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci 42: 1096-1106.
25. Heidinger V, Hicks D, Sahel J, Dreyfus H, (1997) Peptide growth factors but not ganglioside protect against excitotoxicity in rat retinal neurons in vitro. Brain Res 767: 279-288.
26. Ma CH, Taylor JS, (2010) Trophic responsiveness of purified postnatal and adult rat retinal ganglion cells. Cell Tissue Res 339: 297-310.
27. Yamasaki M, Mishima HK, Yamashita H, Kashiwagi K, Murata K, et al. (2005) Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 1050: 15-26.
28. Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, et al. (2009) Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci 50: 4267-4272.
29. Fukuda Y, (1977) A three-group classification of rat retinal ganglion cells: histological and physiological studies. Brain Res 119: 327-334.
30. Dreher B, Sefton AJ, Ni SY, Nisbett G, (1985) The morphology, number, distribution and central projections of Class I retinal ganglion cells in albino and hooded rats. Brain Behav Evol 26: 10-48.
31. Barres BA, Silverstein BE, Corey DP, Chun LL, (1988) Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1: 791-803.
32. Ruiz-Ederra J, Garcia M, Hicks D, Vecino E, (2004) Comparative study of the three neurofilament subunits within pig and human retinal ganglion cells. Mol Vis 10: 83-92.
33. Garcia M, Forster V, Hicks D, Vecino E, (2003) In vivo expression of neurotrophins and neurotrophin receptors is conserved in adult porcine retina in vitro. Invest Ophthalmol Vis Sci 44: 4532-4541.
34. Huxlin KR, Goodchild AK, (1997) Retinal ganglion cells in the albino rat: revised morphological classification. J Comp Neurol 385: 309-323.
35. Sun W, Li N, He S, (2002) Large-scale morophological survey of rat retinal ganglion cells. Vis Neurosci 19: 483-493.
36. Xiang M, Zhou L, Macke JP, Yoshioka T, Hendry SH, et al. (1995) The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci 15: 4762-4785.
37. Kashiwagi F, Kashiwagi K, Iizuka Y, Tsukahara S, (2000) Effects of brain-derived neurotrophic factor and neurotrophin-4 on isolated cultured retinal ganglion cells: evaluation by flow cytometry. Invest Ophthalmol Vis Sci 41: 2373-2377.
38. Manabe S, Lipton SA, (2003) Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci 44: 385-392.
39. Vandenabeele P, Declercq W, Beyaert R, Fiers W, (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5: 392-399.
40. Digicaylioglu M, Lipton SA, (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647.
41. Pregi N, Wenker S, Vittori D, Leiros CP, Nesse A, (2009) TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells. Exp Cell Res 315: 419-431.
42. Quigley HA, Dunkelberger GR, Green WR, (1988) Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 95: 357-363.
43. Chong ZZ, Kang JQ, Maiese K, (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22: 503-514.
44. Kilic U, Kilic E, Soliz J, Bassetti CI, Gassmann M, et al. (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 19: 249-251.
45. Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, et al. (2008) Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 49: 732-742.
46. Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH, et al. (2010) ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci 51: 35-46.
47. Klocker N, Kermer P, Weishaupt JH, Labes M, Ankerhold R, et al. (2000) Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase B signaling. J Neurosci 20: 6962-6967.
48. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, et al. (2006) Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26: 12439-12446.
49. Katsura Y, Okano T, Matsuno K, Osako M, Kure M, et al. (2005) Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 28: 2252-2254.
50. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, et al. (2005) Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353: 782-792.
51. Hernandez C, Fonollosa A, Garcia-Ramirez M, Higuera M, Catalan R, et al. (2006) Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 29: 2028-2033.
52. Chang ZY, Chiang CH, Lu DW, Yeh MK, (2008) Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection. Expert Opin Drug Deliv 5: 1313-1321.
53. Zhang JF, Wu YL, Xu JY, Ye W, Zhang Y, et al. (2008) Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin 29: 1383-1390.